[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Tuberculosis Drug-Global Market Status and Trend Report 2013-2023

February 2018 | 152 pages | ID: T13B6ED7E62EN
MIReports Co., Limited

US$ 2,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Tuberculosis Drug-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Tuberculosis Drug industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Tuberculosis Drug 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Tuberculosis Drug worldwide, with company and product introduction, position in the Tuberculosis Drug market
Market status and development trend of Tuberculosis Drug by types and applications
Cost and profit status of Tuberculosis Drug, and marketing status
Market growth drivers and challenges

The report segments the global Tuberculosis Drug market as:

Global Tuberculosis Drug Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North America
Europe
China
Japan
Rest APAC
Latin America

Global Tuberculosis Drug Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Active TB
Latent TB

Global Tuberculosis Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

First-line anti-TB drugs
Second-line anti-TB drugs

Global Tuberculosis Drug Market: Manufacturers Segment Analysis (Company and Product introduction, Tuberculosis Drug Sales Volume, Revenue, Price and Gross Margin):

Lupin
Otsuka Novel Products
Pfizer
Sandoz
Sanofi
AstraZeneca
Archivel Farma
EIKEN CHEMICAL
Cepheid
Epistem

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

CHAPTER 1 OVERVIEW OF TUBERCULOSIS DRUG

1.1 Definition of Tuberculosis Drug in This Report
1.2 Commercial Types of Tuberculosis Drug
  1.2.1 Active TB
  1.2.2 Latent TB
1.3 Downstream Application of Tuberculosis Drug
  1.3.1 First-line anti-TB drugs
  1.3.2 Second-line anti-TB drugs
1.4 Development History of Tuberculosis Drug
1.5 Market Status and Trend of Tuberculosis Drug 2013-2023
  1.5.1 Global Tuberculosis Drug Market Status and Trend 2013-2023
  1.5.2 Regional Tuberculosis Drug Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Tuberculosis Drug 2013-2017
2.2 Production Market of Tuberculosis Drug by Regions
  2.2.1 Production Volume of Tuberculosis Drug by Regions
  2.2.2 Production Value of Tuberculosis Drug by Regions
2.3 Demand Market of Tuberculosis Drug by Regions
2.4 Production and Demand Status of Tuberculosis Drug by Regions
  2.4.1 Production and Demand Status of Tuberculosis Drug by Regions 2013-2017
  2.4.2 Import and Export Status of Tuberculosis Drug by Regions 2013-2017

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Production Volume of Tuberculosis Drug by Types
3.2 Production Value of Tuberculosis Drug by Types
3.3 Market Forecast of Tuberculosis Drug by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Tuberculosis Drug by Downstream Industry
4.2 Market Forecast of Tuberculosis Drug by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF TUBERCULOSIS DRUG

5.1 Global Economy Situation and Trend Overview
5.2 Tuberculosis Drug Downstream Industry Situation and Trend Overview

CHAPTER 6 TUBERCULOSIS DRUG MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

6.1 Production Volume of Tuberculosis Drug by Major Manufacturers
6.2 Production Value of Tuberculosis Drug by Major Manufacturers
6.3 Basic Information of Tuberculosis Drug by Major Manufacturers
  6.3.1 Headquarters Location and Established Time of Tuberculosis Drug Major Manufacturer
  6.3.2 Employees and Revenue Level of Tuberculosis Drug Major Manufacturer
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 TUBERCULOSIS DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Lupin
  7.1.1 Company profile
  7.1.2 Representative Tuberculosis Drug Product
  7.1.3 Tuberculosis Drug Sales, Revenue, Price and Gross Margin of Lupin
7.2 Otsuka Novel Products
  7.2.1 Company profile
  7.2.2 Representative Tuberculosis Drug Product
  7.2.3 Tuberculosis Drug Sales, Revenue, Price and Gross Margin of Otsuka Novel Products
7.3 Pfizer
  7.3.1 Company profile
  7.3.2 Representative Tuberculosis Drug Product
  7.3.3 Tuberculosis Drug Sales, Revenue, Price and Gross Margin of Pfizer
7.4 Sandoz
  7.4.1 Company profile
  7.4.2 Representative Tuberculosis Drug Product
  7.4.3 Tuberculosis Drug Sales, Revenue, Price and Gross Margin of Sandoz
7.5 Sanofi
  7.5.1 Company profile
  7.5.2 Representative Tuberculosis Drug Product
  7.5.3 Tuberculosis Drug Sales, Revenue, Price and Gross Margin of Sanofi
7.6 AstraZeneca
  7.6.1 Company profile
  7.6.2 Representative Tuberculosis Drug Product
  7.6.3 Tuberculosis Drug Sales, Revenue, Price and Gross Margin of AstraZeneca
7.7 Archivel Farma
  7.7.1 Company profile
  7.7.2 Representative Tuberculosis Drug Product
  7.7.3 Tuberculosis Drug Sales, Revenue, Price and Gross Margin of Archivel Farma
7.8 EIKEN CHEMICAL
  7.8.1 Company profile
  7.8.2 Representative Tuberculosis Drug Product
  7.8.3 Tuberculosis Drug Sales, Revenue, Price and Gross Margin of EIKEN CHEMICAL
7.9 Cepheid
  7.9.1 Company profile
  7.9.2 Representative Tuberculosis Drug Product
  7.9.3 Tuberculosis Drug Sales, Revenue, Price and Gross Margin of Cepheid
7.10 Epistem
  7.10.1 Company profile
  7.10.2 Representative Tuberculosis Drug Product
  7.10.3 Tuberculosis Drug Sales, Revenue, Price and Gross Margin of Epistem

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF TUBERCULOSIS DRUG

8.1 Industry Chain of Tuberculosis Drug
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF TUBERCULOSIS DRUG

9.1 Cost Structure Analysis of Tuberculosis Drug
9.2 Raw Materials Cost Analysis of Tuberculosis Drug
9.3 Labor Cost Analysis of Tuberculosis Drug
9.4 Manufacturing Expenses Analysis of Tuberculosis Drug

CHAPTER 10 MARKETING STATUS ANALYSIS OF TUBERCULOSIS DRUG

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications